Anita Roach, Research Program Manager, reports on new lupus therapies and environmental aspects of lupus from American College of Rheumatology's Annual Scientific Meeting last week in San Francisco.
Anifrolumab significantly reduced disease activity as measured by several SLE composite endpoints and improved symptoms of lupus.
10th Anniversary of the Evelyn V. Hess Award Celebrates Past Honorees
Eight LFA-supported research studies presented during the American College of Rheumatology Annual Scientific Meeting
Fans may be surprised she mentions that she has received chemotherapy for her lupus.
An October 2015 update from Health Educator Sarah Stothers, RN, BS, for options on how to make medications like hydroxychloroquine more affordable.
Under Investigation: Preventive care on the horizon
Dr. Kathleen Sullivan of the Children's Hospital of Philadelphia provides an overview of here study on biomarkers for kidney disease in children and teens with lupus.